Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
319,518,252
-
Share change
-
-8,744,410
-
Total reported value
-
$12,729,928,084
-
Put/Call ratio
-
60%
-
Price per share
-
$39.82
-
Number of holders
-
787
-
Value change
-
-$341,563,872
-
Number of buys
-
351
-
Number of sells
-
319
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q2 2021
As of 30 Jun 2021,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
787 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
319,518,252 shares.
The largest 10 holders included
Dodge & Cox, Capital International Investors, Fisher Asset Management, LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, STATE STREET CORP, Black Creek Investment Management Inc., RENAISSANCE TECHNOLOGIES LLC, and UBS Group AG.
This page lists
787
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.